Newly Approved Drug Therapies (554): Mevacor (lovastatin) tablets, Merck

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Mevacor (lovastatin) tablets

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Merck
Approval Status: Approved March 1999
Treatment for: Cardiology

General Information

Mevacor has been approved for the primary prevention of coronary heart disease in patients without symptomatic cardiovascular disease who have average to moderately elevated total-C and LDL-C and below average HDL-C.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]